Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the Muscle Wasting Disorders market right now?
The market for muscle wasting disorders has experienced a swift expansion in recent times. Its growth is projected to escalate from $15.06 billion in 2024 to $17.54 billion in 2025, with a compound annual growth rate (CAGR) of 16.5%. The historic period growth can be ascribed to the rise in the aging population, a surge in chronic diseases prevalence, advancements in research and development, heightened understanding of early diagnosis benefits, and the emergence of novel therapeutic methodologies.
How fast Is the muscle wasting disorders market expected to grow, and what’s its future value?
In the coming years, the market size for muscle wasting disorders is anticipated to experience a significant expansion. The market is projected to reach $29.67 billion by 2029, growing at a compound annual growth rate (CAGR) of 14.1%. The growth during the predicted period can be credited to factors such as regulatory backing, initiatives for patient advocacy, enhancements in healthcare infrastructure, globalization of clinical studies, and personalized medicine strategies. Significant trends during the forecast period encompass acceptance of telemedicine, advancements in diagnostic technology, innovative products, collaborations and partnerships, developments in therapeutics, molecular mechanism research, and biopharmaceutical innovation.
Get your muscle wasting disorders market report here!
https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report
What are the leading drivers of growth in the muscle wasting disorders market?
The growth of the muscle wasting disorders market is anticipated to surge due to the increasing acceptance of a sedentary lifestyle. This style of living signifies a life where one indulges in minimal or no physical activity or exercise, as it can have detrimental effects on muscle functioning. This can result in the reduction of muscle strength and endurance, contributing to muscle wasting disorders. It can also make it harder for individuals to preserve their muscle mass and functionality. For example, the World Health Organization, a Switzerland-based intergovernmental organization, reported in 2022 that over 80% of adolescents and 27% of adults failed to maintain the recommended levels of physical activity. As a consequence, the mounting prevalence of a sedentary lifestyle is fueling the expansion of the muscle wasting disorders market.
What are the key segments defining the muscle wasting disorders market?
The muscle wasting disorders market covered in this report is segmented –
1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users
Subsegments:
1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents
2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs
3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements
4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions
5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques
6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp
Who are the key players steering the development of the muscle wasting disorders market?
Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.
What emerging trends are influencing the growth of the muscle wasting disorders market?
Leading enterprises in the muscle wasting disorders market are creating cutting-edge products which include unique gene therapies; aimed to significantly improve patient care for those suffering from muscle wasting disorders. Gene therapies, seen as a breakthrough in medical technology, seek to generate a healing response by manipulating gene expression or by modifying the biological characteristics of living cells. A prime example of this came about in June 2023 when the U.S-based biotech company, Sarepta Therapeutics, released Elevidys. It was the first gene therapy to receive approval from the U.S. Food and Drug Administration (FDA) for treating Duchenne muscular dystrophy (DMD) in young patients aged between 4 and 5 years. Elevidys introduces a gene into the body, stimulating the production of a truncated protein that consists of selected segments of the dystrophin protein naturally found in muscle cells. The treatment is administered as a single intravenous drip.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
Which regions are most influential in expanding the muscle wasting disorders market?
North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Anorectal Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report
Generic Musculoskeletal Disorders Drugs Global Market Report 2024
Optic Nerve Disorders Treatment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
